David H. Mack Ph.D.
Net Worth

Last updated:

What is David H. Mack Ph.D. net worth?

The estimated net worth of Dr. David H. Mack Ph.D. is at least $4,097,114 as of 18 Oct 2023. He owns shares worth $19,694 as insider, has earned $225,770 from insider trading and has received compensation worth at least $3,851,650 in PMV Pharmaceuticals, Inc..

What is the salary of David H. Mack Ph.D.?

Dr. David H. Mack Ph.D. salary is $770,330 per year as Co-Founder, Chief Executive Officer, Pres & Director in PMV Pharmaceuticals, Inc..

How old is David H. Mack Ph.D.?

Dr. David H. Mack Ph.D. is 63 years old, born in 1962.

What stocks does David H. Mack Ph.D. currently own?

As insider, Dr. David H. Mack Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
PMV Pharmaceuticals, Inc. (PMVP) Co-Founder, Chief Executive Officer, Pres & Director 12,470 $1.58 $19,694

What does PMV Pharmaceuticals, Inc. do?

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.

PMVP logo
PMVP
PMV Pharmaceuticals, Inc.
$1.58

David H. Mack Ph.D. insider trading

PMV Pharmaceuticals, Inc.

Dr. David H. Mack Ph.D. has made 5 insider trades between 2020-2023, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 198,407 units of PMVP stock on 18 Oct 2023. As of 18 Oct 2023 he still owns at least 12,470 units of PMVP stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 198,407 $0.53 $105,156
Option
Common Stock 85,500 $0.53 $45,315
Option
Employee Stock Option (right to buy) 85,500 $0.53 $45,315
Option
Common Stock 33,000 $0.53 $17,490
Option
Employee Stock Option (right to buy) 33,000 $0.53 $17,490
Option
Stock Option (right to buy) 20,000 $1.37 $27,400
Option
Common Stock 20,000 $1.37 $27,400
Option
Stock Option (right to buy) 9,000 $0.53 $4,770
Option
Common Stock 9,000 $0.53 $4,770
Option
Stock Option (right to buy) 5,500 $0.53 $2,915
Option
Common Stock 5,500 $0.53 $2,915
Sale
Common Stock 26,767 N/A N/A
Option
Common Stock 26,767 N/A N/A
Option
Stock Option (right to buy) 26,767 N/A N/A
Option
Stock Option (right to buy) 1,029 N/A N/A
Option
Common Stock 1,029 N/A N/A
Sale
Common Stock 1,029 N/A N/A
Option
Common Stock 204 N/A N/A
Option
Stock Option (right to buy) 204 N/A N/A
Sale
Common Stock 204 N/A N/A
Option
Stock Option (right to buy) 16,207 $18.12 $293,655
Option
Stock Option (right to buy) 6,207 $35.71 $221,640
Sale
Common Stock 6,207 $35.71 $221,640
Option
Common Stock 6,207 $35.71 $221,640
Sale
Common Stock 7,793 $0.53 $4,130
Option
Stock Option (right to buy) 7,793 $0.53 $4,130
Option
Common Stock 7,793 $0.53 $4,130
Option
Common Stock 17,793 $0.53 $9,430
Option
Common Stock 2,470 N/A N/A
Option
Stock Option (right to buy) 2,470 N/A N/A

PMV Pharmaceuticals key executives

PMV Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: